Rafaela Louise Sales

Rafaela Louise Sales

Auto-generated profile, based on publicly available information

Rafaela Louise Sales

Hospital Regional Hans Dieter Schmidt – Setor de Cardiologia – Joinville (SC), Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2020 in Journal of Cardiac Arrhythmias
Verified
Journal Article
Open access
BPBruna Predabon
Bruna Predabon
ASArthur Zanfrilli Marques Souza
Arthur Zanfrilli Marques Souza
GBGustavo Henrique Sumnienski Bertoldi
Gustavo Henrique Sumnienski Bertoldi
RSRafaela Louise Sales
Rafaela Louise Sales
KLKarila Scarduelli Luciano
Karila Scarduelli Luciano
RRRafael de March Ronsoni
Rafael de March Ronsoni
The World Health Organization (WHO) declared Sars-CoV infection and COVID-19 as a pandemic and global emergency. In addition to viral pneumonia and the severe acute respiratory syndrome (Sars), the heart is affected in some patients due to the detection of biomarkers and reported cases of myocarditis and pericarditis. Therefore, the knowledge of electrocardiogram presentation of these actual infections can guide the choice for the best treatment and can help to reduce misdiagnosis, mainly the acute myocardial infarction, which is the main differential diagnosis.

16 April 2016 in Journal of Cardiac Arrhythmias
Verified
Journal Article
Open access
LGLarissa Freitas Nunes Goldoni
Larissa Freitas Nunes Goldoni
RSRafaela Louise Sales
Rafaela Louise Sales
KLKárila Scarduelli Luciano
Kárila Scarduelli Luciano
AKAlessandra Kraus
Alessandra Kraus
RRRafael de March Ronsoni
Rafael de March Ronsoni
Objetivo: Identificar o perfil dos pacientes que implantaram marcapasso e as suas complicações em um centro terciário de cardiologia do estado de Santa Catarina. Métodos: Estudo unicêntrico, observacional e prospectivo com 81 pacientes submetidos a implante de marcapasso pelo Serviço de Cirurgia Cardiovascular. Resultados: Marcapasso provisório foi necessário em 42 casos (51,8%) e o tempo médio de permanência do marcapasso provisório foi de 2,2 dias. Óbito ocorreu em 3 pacientes (3,7%), entretanto apenas 1 caso (1,2%) foi associado ao implante.Conclusão: As características clínicas e as indicações do implante da população do estudo foram semelhantes às encontradas na literatura, entretanto o número de complicações mostrou-se elevado e o tempo de permanência do marcapasso provisório está além do recomendado

16 April 2020 in Journal of Cardiac Arrhythmias
Verified
Journal Article
Open access
KLKárila Scarduelli Luciano
Kárila Scarduelli Luciano
RCRafael Zoppi Campane
Rafael Zoppi Campane
RSRafaela Louise Sales
Rafaela Louise Sales
AKAlessandra Kraus
Alessandra Kraus
EPErden Ramirez Pestana
Erden Ramirez Pestana
RRRafael de March Ronsoni
Rafael de March Ronsoni
A 50-year-old female patient admitted for etiological syncope investigation. A 24-hour Holter was installed where the record showed the mechanism of sudden cardiac death. Sudden bradycardia caused by paroxysmal atrioventricular block led to torsades de pointes, ventricular fibrillation and death. This case shows the importance of Holter in the chronology of arrhythmic events that lead to sudden death and highlights a poorly reported event – the occurrence of cardiac death during 24-hour Holter monitoring.

16 April 2016 in Journal of Cardiac Arrhythmias
Verified
Journal Article
Open access
LGLarissa Freitas Nunes Goldoni
Larissa Freitas Nunes Goldoni
RSRafaela Louise Sales
Rafaela Louise Sales
KLKárila Scarduelli Luciano
Kárila Scarduelli Luciano
AKAlessandra Kraus
Alessandra Kraus
RRRafael de March Ronsoni
Rafael de March Ronsoni
Objective: To identify the profile of patients who implanted pacemakers and their complications in a tertiary cardiology center in the state of Santa Catarina. Methods: Unicentric, observational and prospective study with 81 patients submitted to pacemaker implantation by the Cardiovascular Surgery Service. Results: Provisional pacemaker was necessary in 42 cases (51.8%) and the average time of temporary pacemaker insertion was 2.2 days. Death occurred in 3 patients (3.7%), however only 1 case (1.2%) was associated with the implant. Conclusion: The clinical characteristics and indications of the implant in the study population were similar to those found in the literature, however the number of complications was high and the length of stay of the provisional pacemaker is beyond that recommended.